• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坏疽性脓皮病是否与实体恶性肿瘤相关?一项基于人群的队列研究的新见解。

Is pyoderma gangrenosum associated with solid malignancies? Insights from a population-based cohort study.

机构信息

Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

出版信息

Australas J Dermatol. 2021 Aug;62(3):336-341. doi: 10.1111/ajd.13631. Epub 2021 Jun 2.

DOI:10.1111/ajd.13631
PMID:34076886
Abstract

BACKGROUND

The question of whether solid malignancies (SMs) are associated with pyoderma gangrenosum (PG) remains to be conclusively answered.

OBJECTIVE

To evaluate the risk of SM among patients with PG and the odds of PG after a diagnosis of SM.

METHODS

A population-based retrospective cohort study was conducted to study the risk for SM in patients with PG (n = 302) as compared with age-, sex- and ethnicity-matched control subjects (n = 1799). A case-control design was used to estimate the odds of PG in those with a preexisting history of SM.

RESULTS

The prevalence of a preexisting SM was comparable in patients with PG and controls (7.5% vs. 8.8%, respectively; P = 0.490). The odds of having PG following a diagnosis of a SM was not statistically increased (OR, 0.85; 95% CI, 0.53-1.36). The incidence of SM was 6.8 (95% CI, 3.5-12.2) and 7.9 (95% CI, 6.1-10.1) per 1000 person-years among patients with PG and controls, respectively. Patients with PG were not more likely to develop SM as compared to controls (HR, 0.86; 95% CI, 0.44-1.69). Patients with a dual diagnosis of PG and SM were older and had more frequent comorbid conditions and increased mortality.

CONCLUSIONS

SM is not associated with provoking PG, and patients with PG are not at an increased risk of developing SM. A thorough routine screening for SM in patients with new-onset PG is an unnecessary approach based on the study findings.

摘要

背景

实体恶性肿瘤(SM)是否与坏疽性脓皮病(PG)有关,仍有待明确回答。

目的

评估 PG 患者发生 SM 的风险,以及 SM 诊断后发生 PG 的几率。

方法

采用基于人群的回顾性队列研究,比较 302 例 PG 患者(n=302)和年龄、性别和种族匹配的对照组(n=1799)中 SM 的发病风险。采用病例对照设计来估计既往存在 SM 病史的患者发生 PG 的几率。

结果

PG 患者和对照组中,既往 SM 的患病率相当(分别为 7.5%和 8.8%;P=0.490)。SM 诊断后发生 PG 的几率并无统计学差异(OR,0.85;95%CI,0.53-1.36)。PG 患者的 SM 发病率为 6.8(95%CI,3.5-12.2),对照组为 7.9(95%CI,6.1-10.1)/1000 人年。与对照组相比,PG 患者发生 SM 的风险并不更高(HR,0.86;95%CI,0.44-1.69)。PG 合并 SM 的双重诊断患者年龄更大,合并症更多,死亡率更高。

结论

SM 与 PG 并无关联,PG 患者发生 SM 的风险也不会增加。根据本研究结果,对新诊断为 PG 的患者进行广泛筛查以寻找 SM 并无必要。

相似文献

1
Is pyoderma gangrenosum associated with solid malignancies? Insights from a population-based cohort study.坏疽性脓皮病是否与实体恶性肿瘤相关?一项基于人群的队列研究的新见解。
Australas J Dermatol. 2021 Aug;62(3):336-341. doi: 10.1111/ajd.13631. Epub 2021 Jun 2.
2
Chronic renal comorbidities in pyoderma gangrenosum: a retrospective cohort study.坏疽性脓皮病的慢性肾脏合并症:一项回顾性队列研究。
Immunol Res. 2021 Jun;69(3):249-254. doi: 10.1007/s12026-021-09187-3. Epub 2021 Apr 22.
3
Estimating the Odds of Ulcerative Colitis-Associated Pyoderma Gangrenosum: A Population-Based Case-Control Study.评估溃疡性结肠炎相关性坏疽性脓皮病的发病几率:一项基于人群的病例对照研究。
Dermatology. 2021;237(3):323-329. doi: 10.1159/000512931. Epub 2021 Mar 1.
4
Pyoderma gangrenosum associated with solid organ malignancies.与实体器官恶性肿瘤相关的坏疽性脓皮病。
Int J Dermatol. 2015 Sep;54(9):e351-7. doi: 10.1111/ijd.12796. Epub 2015 Mar 13.
5
Quantification of the relationship between pyoderma gangrenosum and Crohn's disease: a population-based case-control study.定量分析坏疽性脓皮病与克罗恩病的关系:一项基于人群的病例对照研究。
Scand J Gastroenterol. 2020 Jul;55(7):814-818. doi: 10.1080/00365521.2020.1786849. Epub 2020 Jul 7.
6
Rheumatoid arthritis and pyoderma gangrenosum: a population-based case-control study.类风湿性关节炎与坏疽性脓皮病:一项基于人群的病例对照研究。
Clin Rheumatol. 2021 Feb;40(2):521-528. doi: 10.1007/s10067-020-05253-7. Epub 2020 Jul 1.
7
Hematological malignancy-associated pyoderma gangrenosum: evaluating the magnitude of the association.血液系统恶性肿瘤相关坏疽性脓皮病:评估两者关联的程度
Front Med (Lausanne). 2024 Jul 25;11:1425454. doi: 10.3389/fmed.2024.1425454. eCollection 2024.
8
Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014.术后坏疽性脓皮病(PG):1994 年至 2014 年 20 年期间梅奥诊所的经验。
J Am Acad Dermatol. 2015 Oct;73(4):615-22. doi: 10.1016/j.jaad.2015.06.054. Epub 2015 Jul 21.
9
The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.年龄与坏疽性脓皮病临床表现和合并症的关系。
JAMA Dermatol. 2018 Apr 1;154(4):409-413. doi: 10.1001/jamadermatol.2017.5978.
10
Association of All-Cause and Cause-Specific Mortality Risks With Pyoderma Gangrenosum.坏疽性脓皮病与全因和病因特异性死亡率风险的关联。
JAMA Dermatol. 2023 Feb 1;159(2):151-159. doi: 10.1001/jamadermatol.2022.5437.

引用本文的文献

1
Disrupted Redox Regulation and Inflammatory Response in Pyoderma Gangrenosum.坏疽性脓皮病中氧化还原调节和炎症反应的破坏
Life (Basel). 2025 Apr 6;15(4):611. doi: 10.3390/life15040611.
2
Facial pyoderma gangrenosum associated with fallopian tube carcinosarcoma.面部坏疽性脓皮病伴输卵管癌肉瘤
Clin Case Rep. 2023 Oct 15;11(10):e8065. doi: 10.1002/ccr3.8065. eCollection 2023 Oct.